thomsen-friedenreich antigen and qs 21

thomsen-friedenreich antigen has been researched along with qs 21 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Danishefsky, S; Diani, M; Fernandez, C; Livingston, P; Musselli, C; Ragupathi, G; Scher, HI; Slovin, SF; Verbel, D	1

Trials

1 trial(s) available for thomsen-friedenreich antigen and qs 21

Article	Year
Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer. Cancer immunology, immunotherapy : CII, 2005, Volume: 54, Issue:7 Topics: Adjuvants, Immunologic; Aged; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Cancer Vaccines; Hemocyanins; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Saponins; Vaccination; Vaccines, Conjugate	2005

Article

Year

Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer.

Cancer immunology, immunotherapy : CII, 2005, Volume: 54, Issue:7

Topics: Adjuvants, Immunologic; Aged; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Cancer Vaccines; Hemocyanins; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Saponins; Vaccination; Vaccines, Conjugate

2005